Lab R.A.T.S عمومي
[search 0]
أكثر
تنزيل التطبيق!
show episodes
 
Lab Rats to Unicorns is a podcast that aims to demystify the process of creating a great company in life sciences. Under the guidance of our host, John Flavin, you will hear personal stories of creation, be able to understand how great companies are created, and get insights into the many ways that you as an individual can engage in the creation of tomorrow’s life science companies. From the lab rat, signifying the process of invention and discovery, to the unicorn, signifying market success ...
  continue reading
 
Artwork

1
Lab Rats-Anatomy and Physiology Review

Lab Rats-Anatomy and Physiolog

Unsubscribe
Unsubscribe
شهريا
 
**NOT MEDICAL ADVICE** Anatomy and Physiology topics explained in 10-20 min. This podcast can be used as review, lecture prep (at the 200ish level), or recreational learning. Episodes are based on areas of peak confusion, and questions asked by lab students in the 211 lab that I assist in. Cover art is a drawing by your host, Frances Cronin. Support this podcast: https://podcasters.spotify.com/pod/show/lab-rat/support
  continue reading
 
Artwork

1
Lab Rats Culture

Stephen "tWitch" Boss

Unsubscribe
Unsubscribe
شهريا
 
Stephen "tWitch" Boss will be bringing in depth interviews with his favorite dancers, artists, and creatives to talk through their passion, process, and execution. Join Stephen as he dives into these conversations hoping to bring practical and useful inspiration to the next generation of creators. Theme music by James B-Dash Derrick Executive Producer/Host Stephen “tWitch” Boss Producer/Audio Engineer Samee Junio Video Producer Joe White FAB Factory BTB Management
  continue reading
 
Loading …
show series
 
In this episode, John Flavin sits down with Dr. Ivan Liachko, co-founder and CEO of Phase Genomics, a company at the forefront of genomics and microbiome research. Ivan shares his journey from a young immigrant fascinated by biology in Ukraine to a biotech leader based in Seattle. His academic path began with a keen interest in genetics, leading hi…
  continue reading
 
In this insightful episode of Lab Rats to Unicorns, Steve Lehmann sits down with Dr. Zhenpeng Qin, Associate Professor of Mechanical and Bioengineering at the University of Texas at Dallas. Dr. Qin shares his groundbreaking work in biomedical engineering, focusing on the development of nanomaterials to advance diagnostics and therapeutic delivery. …
  continue reading
 
Join us for a conversation with Dr. Raghu Kalluri, a leading figure in cancer biology, who serves as the Chair of the Department of Cancer Biology at MD Anderson Cancer Center. With over 300 publications, multiple successful biotech ventures, and groundbreaking work in exosome research, Dr. Kalluri discusses the intricate relationship between scien…
  continue reading
 
Join us on Lab Rats to Unicorns as we dive into the career of Michael Torres, CEO of Crossbridge Bio. With a Ph.D. in cancer biology and a background in equity research, Michael has been at the forefront of developing cutting-edge oncology treatments. In this episode, he discusses the evolution of antibody-drug conjugates (ADCs) and the process of …
  continue reading
 
Join us on Lab Rats to Unicorns as we dive into the inspiring journey of Dr. Jochen Reiser, President of UTMB and CEO of UTMB Health System. A nephrologist, healthcare executive, and biotech entrepreneur, Jochen shares insights from his transition into the U.S. medical landscape, his pioneering research in kidney disease, and the founding of Walden…
  continue reading
 
Join Steve Lehmann & Jeremy Langsam from Portal's Stargaze team on a bimonthly segment of Lab Rats to Unicorns: Rising Stars. In this episode, they explore the groundbreaking work of Zachi Attia, the Director of Artificial Intelligence at Mayo Clinic. With a rich background in electrical engineering and a Ph.D. in Bioinformatics, Zachi discusses hi…
  continue reading
 
In this captivating episode of Lab Rats to Unicorns, we journey into the universe of biotechnology with Steve Lehmann, Director of Venture Operations, and Jeremy Langsam, Venture Analyst at Portal Innovations. In this episode, Steve and Jeremy share their insights into the relay race of innovation—from the "aha" moments in the lab to creating groun…
  continue reading
 
In this episode, Dr. Walter E. Massey shares insights from his illustrious career in science and academia, detailing his journey, evolving focus, and key advancements in physics that have shaped his work. He discusses significant leadership decision points, his approach to decision-making, and offers guidance on preparing for impactful choices. Ref…
  continue reading
 
Episode 54 of LRTU wants us to know about Tony Martignetti, the founder and chief inspiration officer at Inspired Purpose! With over 25 years of experience in the life sciences and tech sectors, Tony brings a wealth of knowledge and a unique perspective on leadership. He shares his journey from being a pre-med major to holding pivotal roles in biop…
  continue reading
 
Join us on episode 53 of Lab Rats to Unicorns as we sit down with Solomon Wilcots, a former NFL player who has transitioned into a health advocate. Solomon invites us on his remarkable journey from the competitive arenas of professional sports into the insightful world of broadcast television, and further into the impactful realm of health communic…
  continue reading
 
In this episode of "Lab Rats to Unicorns," recorded at TMC's Helix Park in Houston during a Portal Pours event, we're joined by a distinguished panel led by featured host Ritu Shah, a seasoned expert in the biopharma industry and Managing Director at Portal Innovations. The conversation features: Sarah Hein, the visionary founding CEO of March Bios…
  continue reading
 
In this live taping of Lab Rats to Unicorns, John Flavin and Jeff Karp discuss the challenges and triumphs of bringing lab research to market, the evolving landscape of biotech startups, and the importance of interdisciplinary collaboration in driving scientific breakthroughs. Dr. Jeff Karp is a renowned figure in the biotechnology sector, known fo…
  continue reading
 
In this episode of "Lab Rats to Unicorns," we're thrilled to spotlight Ritu Shah, the Managing Director at Portal Innovations, whose distinguished career in the biopharma industry spans over two decades. Ritu's unparalleled expertise shines in her role, where she's instrumental in driving growth and enhancing the value of portfolio companies. Speci…
  continue reading
 
In this episode, we venture into the intricate world of life science innovation spaces with James Lewis and Mason Ailstock. From the nuances of creating standout spaces that cater to diverse innovator types to the importance of location in driving differentiation, we dissect what truly makes an innovation hub thrive. As we spotlight their landmark …
  continue reading
 
We're thrilled to welcome Kenneth T. Christensen, Provost and Senior Vice President for Academic Affairs at Illinois Institute of Technology to this episode of LRTU! With a career spanning decades at the forefront of engineering and academia, Christensen brings a wealth of knowledge and insight. In this episode, we'll explore the intersection of ac…
  continue reading
 
Erika Jefferson stands at the intersection of leadership, innovation, and advocacy in the STEM world. She is the President and Founder of Black Women in Science and Engineering (BWISE), an initiative born out of the need to bridge the leadership gap for Black women in STEM fields. Erika's academic foundation, with a BS in Chemical Engineering from …
  continue reading
 
On this episode of "Lab Rats to Unicorns," we sit down with Julie Gilmore, Ph.D., Lilly’s vanguard in bridging the worlds of big pharma, startups, and academia. With over two decades at Lilly, Julie unpacks the role big pharma plays in scientific innovation and the multifaceted career paths and opportunities within it. We'll delve into her experien…
  continue reading
 
This episode features a conversation in front of a live audience in Atlanta with Dr. James Lillard. Dr. Lillard is a Distinguished Fellow of AAI and Fellow of NAI and AAAS that uses both in silico and in vivo methods to develop biologics or molecular tests to better treat or diagnose, respectively, chronic diseases. His research involves dissecting…
  continue reading
 
Dr. Todd Sherer has dedicated over three decades to the advancement of academic technology transfer, ensuring research, especially federally-funded, translates into life-saving applications for the public. As the helm of Emory’s Office of Technology Transfer since 2003, he transformed the department into a global leader in the field. Instrumentally…
  continue reading
 
e.043!! Learn about & from: Lesley Millar-Nicholson! Ms. Millar-Nicholson is the Executive Director of the Massachusetts Institute of Technology, Technology Licensing Office (TLO) and was part of the founding leadership team of the recently formed MIT Office of Strategic Alliances and Technology Transfer (OSATT). As TLO Executive Director, she lead…
  continue reading
 
Ryan Meyers is a skilled biotech executive with significant experience in management consulting, venture capital and company creation. He is the co-founder of both AddGraft Therapeutics – a novel skin based cell therapy platform – as well as Alnair Therapeutics - which aims to develop a platform technology that improves the delivery of drugs to dif…
  continue reading
 
e.041 is another live audience recording! Taped in partnership with Marcus Whitney and his awesome podcast Health: Further, this one takes a unique form. Jump into a wide conversation from the macroeconomic environment entrepreneurs are facing currently to broadening the health equity conversation. The conversation explores the perspectives of Keda…
  continue reading
 
e.040: David Steinberg is a General Partner at Longwood Fund. He is currently Chairman of the Board of Longwood portfolio companies Photys Therapeutics and Be Biopharma, where he also served as founding Chief Executive Officer, and serves on the board of Longwood portfolio companies AAVantgarde Bio, Carbon Biosciences, Lassen Therapeutics, and Rect…
  continue reading
 
e.039 was recorded in front of a whole audience of ppl in dorchester because that seemed like a pretty fun idea. in this episode, Rahul Dhanda (founder, ceo & prez of Syntis Bio) gives us the story of his career; teaches us a few lessons on #biotech research, startup creation & culture development; and he breaks DOWN the trap and residual harm of s…
  continue reading
 
James Dahlman is a biomedical engineer who works at the intersection of nanotechnology, molecular biology, and genomics. He is an associate professor at Georgia Institute of Technology and Emory School of Medicine, and the director of the Lab for Precision Therapies. His lab designs drug delivery vehicles that target RNA and other nucleic acids to …
  continue reading
 
Erandi De Silva is a biotech founder and scientist who co-founded Forge Biologics, a gene therapy development and manufacturing company headquartered in Columbus, Ohio. She serves as the Senior Vice President of Product Development, overseeing the pipeline of disease-modifying AAV-based therapies for rare genetic diseases, automation initiatives an…
  continue reading
 
phew, huh, pssh, hmm….hard to maintain a cool composure for this week’s guest…dr. omar farha is an ESTEEMED scientist with an unwavering passion for advancing the field of chemistry and fostering innovation. he completed those undergrad studies at fullerton college before pursuing his PHD at UCLA, where he specialized in inorganic chemistry. dr. fa…
  continue reading
 
y’all… even we aren’t ready for this superstar… Dr. Courtney Law is a career scientist with remarkable achievements that exemplify her dedication to impacting human health. Law received her B.S. in Chemistry & Ph.D. in Pharmaceutical Sciences and Medicinal Chemistry & Natural Products from the University of North Carolina at Chapel Hill. after comp…
  continue reading
 
We had the great privilege of being joined by two exceptional guests from Northwestern University for this live episode! And to make it even better, Kevin O’Connor joined the conversation as a co-host! First, let us introduce Dr. Richard B. Silverman, an esteemed medicinal chemist and dedicated educator, who holds the title of Patrick G. Ryan/Aon P…
  continue reading
 
okie okie we can’t contain our excitement fr!!! maria thacker goethe is equally deeply committed to her important non-profit work & the development of biotechnology ecosystems!!! thacker goethe received her B.A from Sweet Briar College before attending Tulane School of Public Health & Tropical Medicine where she studied health marketing/communicati…
  continue reading
 
lol like how are some people just... able 2 do everything... like omg... Kyyah Abdul is a multi-talented and deeply passionate leader in public health who has not gone unnoticed!!! Abdul received her Bachelor's from the University of New Haven in Biology concentrated in Pre-Medical Studies and her Master's in Public Health from Charles R. Drew Univ…
  continue reading
 
we’re honestly taken aback by this one… truly in awe… Nakia Melecio is truly a leader, uniquely juxtaposing his skills to help researchers commercialize in the sciences. Melecio received his B.A in Cognitive Science & a Master’s in education/teaching, learning & educational technology from Ashford University before receiving his Ph.D. from The Univ…
  continue reading
 
Evonne Sepsis dedicates herself to the continued growth of the life sciences ecosystem. Sepsis received her undergraduate degree from Northwestern University and her MBA from the Yale School of Management. She started her career in investment banking at Salomon Brothers, was then the head of investment banking at Susquehanna Financial Group, and wa…
  continue reading
 
okay… like… this is really really BIG!!! Dr. Dennis Liotta is the physical manifestation of true diligence, dedication, & commitment. Liotta obtained his Ph.D. in organic chemistry from the City University of New York in 1974. following this, he dedicated himself to drug discovery & is recognized as “one of the premier discoverers of novel therapeu…
  continue reading
 
whew… this one is… just. wow. D. Gayathri Srinivasan’s career and research accomplishments are truly remarkable. Srinivasan received her Ph.D. from The Ohio State University in Microbiology. She then headed to the Massachusetts Institute of Technology to serve as a postdoctoral fellow before serving as a Technology Licensing Associate there. she se…
  continue reading
 
Victor Pascucci III is a cofounder and Managing General Partner at Energy Capital Ventures and is a passionately devoted career venture capitalist and strategic investor. He received his BA in Communications from Bowling Green State University and his law degree from the University of Toledo. Pascucci has extensive career experience, ranging from v…
  continue reading
 
Dr. Carnahan received his BS in Biology and BS in Psychology from Indiana University, jumped into the industry, working for Eli Lilly in both the US and France, then he came back to academia as a researcher at the Institut Pasteur in Paris, France. He completed his Ph.D. in Cell Biology at Vanderbilt University and his post-doc in the laboratory of…
  continue reading
 
dr. meesha dogan's commitment to entrepreneurship is genuinely, like actually unparalleled & laudable!!! dogan received both a joint bachelor's and master's in chemical engineering and a Ph.D. in biomedical engineering from the University of Iowa. upon leaving Iowa in 2017,,, Dogan co-founded Cardio Diagnostics, where she now acts as CEO and co-fou…
  continue reading
 
okay… this one is honestly,,, soso exciting… like,,, dr. shana kelley is a highly driven and passionate scientist and intellectual!!! kelley received her B.S from Seton Hall University and promptly pursued her graduate and doctoral studies at the California Insitute of Technology!!! kelley's work in academia is outstanding and noteworthy; she has b…
  continue reading
 
this is a super fun one!!! this week’s episode features Dr. Jim Audia,,, a deeply intelligent & passionate scientist! after receiving his bachelor’s & Ph.D in chemistry from the University of South Carolina, Audia did his postdoc at Yale University!!! he has flourished throughout his decades-long professional career, notably working at Eli Lilly & …
  continue reading
 
e.022: you’re in for,,, a treat! Swamy Vijayan is a creator at heart. he’s run three companies as founder & ceo,,, and has deep experience in bringing interdisciplinary technologies to the market. he received a Ph.D in physics from the University of Pennsylvania and immediately began his professional career working in optics, molecular biology, nan…
  continue reading
 
we are… like so so lucky to have the,,, wonderful & awe-inspiring dr. cathryn nagler on the show this week to learn more about her, her entrance into the world of biotech, & discuss her work at her academic start-up company ClostraBio, the microbiome, food allergies & more! dr. nagler graduated w/ honors from Barnard College at Columbia University.…
  continue reading
 
e.020...omg...don't even get us STARTED! We are here to learn about Dr. Garry Cooper – the Co-founder and CEO of Rheaply, a Chicago-based tech company that enables Fortune 500 companies, government agencies, cities, and universities to enter the circular economy through reuse. He also serves on the boards of directors of P33 Chicago and 1871, and t…
  continue reading
 
e.019 follows the journey of Dr. Jim Sullivan––the co-founder and CEO of Vanqua Bio. Tune in to hear John Flavin and the Chicago Biomedical Consortium Entrepreneurial Fellows engage with Jim, aiming to learn more about the life sciences industry and the different means of entry (to various opportunities). Previously, Jim was the Vice President of R…
  continue reading
 
Go Big or Go Home: John Flavin talks Texas-style life sciences with innovation leaders Tom Luby and Sarah Hein from Texas Medical Center Innovation in e.018. New developments in Houston are setting the stage for accelerated growth in the start-up ecosystem. Investments being made by member institutions such as MD Anderson, Baylor, Texas A&M, Texas,…
  continue reading
 
Following the voices of Michelle Hoffman, Azurii Collier, John Conrad and John Flavin, e.017 means to reach a community-based perspective, focusing on the factors that contribute to and resist change/growth in emerging life science ecosystems, especially Chicago. Azurii Collier is the Director of Enterprise Innovation at AbbVie and the National Pre…
  continue reading
 
e.016 meets Dr. Mandell - a scientist, entrepreneur, and leading expert in synthetic biology, protein engineering, artificial intelligence, and biological and medical informatics. Together with Dr. George Church, he leveraged Genomically Recoded Organisms (GROs) to produce the first proteins with stability and function dependent on non-standard ami…
  continue reading
 
e.015 thinks Sree Kant is pretty phenomenal. Sree is an experienced biotech executive, and company builder. Over a 20-year career in life sciences and healthcare, he has worked across investing, operational, advisory, and entrepreneurial roles and functions. He is passionate about translating cutting edge science into therapies that significantly c…
  continue reading
 
Dr. Lishan Aklog's journey to entrepreneurial and professional success was not an easy road. As a teenager Dr. Aklog fled political violence in Ethiopia, which led him to become especially active in philanthropic organizations later in life. Dr. Aklog is a member of the NY Executive Committee, the Africa Advisory Committee, and the Human Rights Wat…
  continue reading
 
In episode 013, Dr. Omer Inan shares insight on academia and entrepreneurship –– for example, how do they interact…and can a person pursue both? Omer earned his B.S., M.D. and Ph.D. degrees in Electrical Engineering from Stanford University. During his studies, he worked at ALZA Corporation in the Drug Device Research and Development Group, then Co…
  continue reading
 
Loading …

دليل مرجعي سريع